Skyhawk Therapeutics Announces Positive First Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease
SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering…
GIGABYTE Announces the Availability of its AI-enhanced AORUS X870E X3D Series Motherboards for AMD Ryzen X3D Processors
TAIPEI, Sept. 17, 2025 /PRNewswire/ -- GIGABYTE, the world's leading computer brand,…
LCM Partners Announces 3.8 Billion First Close of Credit Opportunities 5 Strategy
LONDON, Sept. 16, 2025 /PRNewswire/ -- LCM Partners, one of Europe's leading…
Pasithea Therapeutics Announces Activation of Clinical Trial Sites in South Korea for Phase 1/1b Trial of PAS-004 in Adult NF1 Patients
MIAMI, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA)…
Happiest Health Announces Ethics in Healthcare Summit 2025: A Platform for Trust, Transparency & Reform
BENGALURU, India, Sept. 16, 2025 /PRNewswire/ -- Happiest Health, India's leading wellness…
izmomicro Announces Breakthrough in High-Power Motor Control Technology
BANGALORE, India, Sept. 16, 2025 /PRNewswire/ -- izmomicro (www.izmomicro.com), a division of izmo…
Arkieva announces Anand Iyer as CEO
Supply chain planning veteran brings technical expertise, experience scaling go-to-market functions to…
BitMine Immersion (BMNR) Announces Crypto and Cash Holdings of $10.8 Billion, ETH Holdings Exceeding 2.151 Million
BitMine Crypto + Cash Holdings + "Moonshots" total $10.771 billion, including 2.151…
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
September 12, 2025 16:15 ET | Source: Fortrea Holdings Inc DURHAM, N.C.,…
Curanex Pharmaceuticals Inc. Announces Exercise of the Over-Allotment Option by Underwriters
Jericho, New York, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals Inc.…
